Jeffrey Leiden is stepping down as CEO of Vertex Pharmaceuticals. The company has reportedly named a new CEO, with some sources identifying the new leader as Reshma Kewalramani, the current chief medical officer. However, the exact details of the succession plan and its timing are unclear, with one report referencing a plan from 2012.